The Fourth Circuit Upholds CMS’ Definition of “Line-Extension Drug” and “New Formulation” By Sophia R. Gaulkin —

https://www.thefdalawblog.com/2024/04/the-fourth-circuit-upholds-cms-definition-of-line-extension-drug-and-new-formulation/?utm_source=rss&utm_medium=rss&utm_campaign=the-fourth-circuit-upholds-cms-definition-of-line-extension-drug-and-new-formulation